Early Phase Clinical Trial Units (EPCTU)
Awarded Award Notice Posted
- Solicitation number
- 75N93022D00015
- Agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- Awarded
- to Allucent Government Services (Us) LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93022D00015 Federal IDV award
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a contract to PHARM-OLAM, LLC on January 14, 2021 to implement Early Phase Clinical Trial Units (EPCTU) to conduct Phase 0 to Phase II clinical trials and proof-of-concept studies domestically and internationally for new or tested investigational products such as small molecules, monoclonal antibodies, vaccines and other immunomodulatory products against infectious diseases, with Phase III studies conducted occasionally. The total value of the contract awarded to PHARM-OLAM, LLC is $346,610,277.00 to be paid over the period of performance.
Notice text
See Attachment for RFP-NIAID-NIH-AI-75N93020R00023.
Awarded contract 75N93022D00015 to PHARM-OLAM, LLC for 346610277.00 on 2021-01-14.
Attachments
| File | Type | Posted |
|---|---|---|
| RFP-NIAID-NIH-AI-75N93020R00023 Final.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Solicitation | |
| Early Phase Clinical Trial Units (EPCTU) | Pre-Solicitation |
And 1 more award notice.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity